MARK2 and schizophrenia: Previous in silico work in our laboratory examined altered serine/threonine kinase activity in chronic schizophrenia utilizing human postmortem brain tissue from the anterior cingulate cortex (ACC) and found increased PKA levels in samples from schizophrenia subjects compared to control subjects [31,32].